(Q56031831)

English

Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery

No description defined

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery (English)

0 references

hereditary angioedema

1 reference

based on heuristic

inferred from title

author name string

Andreas Lehmann

1

0 references

language of work or name

0 references

publication date

9 July 2008

0 references

Expert Opinion on Biological Therapy

0 references

8

0 references

8

0 references

1187-1199

0 references

The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Nonallergic angioedema: role of bradykinin

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

C1 inhibitor deficiency: consensus document

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Regulation of C1 inhibitor synthesis

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Hereditary angioedema with normal C1-inhibitor activity in women

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Hereditary angioedema: a broad review for clinicians

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Asphyxiation by laryngeal edema in patients with hereditary angioedema

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Hereditary angioedema: its diagnostic and management perspectives

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

N- and O-glycans of recombinant human C1 inhibitor expressed in the milk of transgenic rabbits

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Established and new treatments for hereditary angioedema: An update.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Iterative optimization of high-affinity protease inhibitors using phage display. 2. Plasma kallikrein and thrombin

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

New therapies for hereditary angioedema: disease outlook changes dramatically

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

DX-88 and HAE: a developmental perspective

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Coagulation disorders of cardiopulmonary bypass: a review

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Aprotinin in cardiac surgery: a review of conventional and novel mechanisms of action.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

The hemostatic defect of cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Impact of off-pump coronary artery bypass surgery on postoperative bleeding: current best available evidence

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Current Trends and Technique in OPCAB Surgery

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Minimally invasive closed circuit versus standard extracorporeal circulation for aortic valve replacement.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Significant reduction in blood loss in patients undergoing minimal extracorporeal circulation.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Aprotinin and the systemic inflammatory response after cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Aprotinin in perspective

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Review and application of serine protease inhibition in coronary artery bypass graft surgery

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

A comparison of aprotinin and lysine analogues in high-risk cardiac surgery

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

The risk associated with aprotinin in cardiac surgery

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Aprotinin and anaphylaxis: analysis of 12,403 exposures to aprotinin in cardiac surgery

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Tranexamic acid: a review of its use in surgery and other indications

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

The impact of administration of tranexamic acid in reducing the use of red blood cells and other blood products in cardiac surgery

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Plasma tranexamic acid concentrations during cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Antifibrinolytic use in adult cardiac surgery

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

The use of desmopressin as a hemostatic agent: a concise review

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Novel intravenous antithrombins

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

The plasma kallikrein-kinin system: its evolution from contact activation

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Evaluation of a novel kallikrein inhibitor on hemostatic activation in vitro

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Kallikrein-kinin in stroke, cardiovascular and renal disease

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

The role of angiotensin receptor blockers in the management of chronic heart failure

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Role of bradykinin B1 and B2 receptors in normal blood pressure regulation

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.8.1187

21 January 2018

Identifiers

10.1517/14712598.8.8.1187

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56031831&oldid=1526454337"